MKI67 and astrocytoma (excluding glioblastoma): Ki‐67 LI is frequently used for the assessment of proliferative activity in various tumors, and high Ki‐67 LI in tumor tissues is generally correlated with poor survival in breast and lung carcinomas, astrocytoma, and meningioma patients 29.